Bridgeway Capital Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-28,900
| Closed | -$190K | – | 1383 |
|
|
2020
Q3 | $190K | Sell |
28,900
-280
| -1% | -$1.84K | ﹤0.01% | 1183 |
|
|
2020
Q2 | $217K | Buy |
+29,180
| New | +$217K | ﹤0.01% | 1133 |
|
|
2019
Q4 | – | Sell |
-7,450
| Closed | -$78K | – | 1405 |
|
|
2019
Q3 | $78K | Hold |
7,450
| – | – | ﹤0.01% | 1257 |
|
|
2019
Q2 | $127K | Sell |
7,450
-5,000
| -40% | -$85.2K | ﹤0.01% | 1227 |
|
|
2019
Q1 | $420K | Hold |
12,450
| – | – | 0.01% | 1075 |
|
|
2018
Q4 | $364K | Sell |
12,450
-2,500
| -17% | -$73.1K | ﹤0.01% | 1089 |
|
|
2018
Q3 | $921K | Buy |
14,950
+10,000
| +202% | +$616K | 0.01% | 913 |
|
|
2018
Q2 | $365K | Hold |
4,950
| – | – | ﹤0.01% | 1213 |
|
|
2018
Q1 | $325K | Buy |
+4,950
| New | +$325K | ﹤0.01% | 1187 |
|